Clostridium difficile (C. difficile) has reached an epidemic state and is the most common infectious cause of diarrhea in hospitals. Healthcare providers are seeing increased severity and recurrence rates of the infection. In response, Mayo Clinic in Rochester, Minn. has opened a C. difficile Clinic at the Rochester campus.
C. difficile infection is a major cause of diarrhea in inpatients and outpatients that happens after antibiotic exposure. It is associated with several complications, including severe and severe-complicated infection, recurrent infection and treatment failure.
New treatment options are now available and we believe that a clinic dedicated to C. difficile will help improve patient care and outcomes, says Sahil Khanna, MBBS, a Mayo Clinic gastroenterologist.
Khanna and Darrell Pardi, MD, also a Mayo Clinic gastroenterologist, staff the clinic.
One new treatment available is fecal transplant. Also known as stool transplant, the procedure restores healthy intestinal bacteria by placing donor stool in the colon. Additionally, there is ongoing research on the gut microflora in collaboration with the Center for Individualized Medicine at Mayo Clinic.
The C. difficile Clinic will provide some of the following:
- Multidisciplinary approach to evaluation and management of C. difficile infection with a team consisting of physicians, nurses, study coordinators and research personnel with expertise in the gut microflora.
- Evaluation and management of patients with initial episodes; recurrent and relapsing infection; severe and severe-complicated infection; and infection nonresponsive to conventional therapies
- Expertise in all facets of treatment, including oral drug therapy; fecal microbiota transplantation for recurrent and nonresponding infection; options of related and standardized stool donors; clinical trials for new therapies
- Ongoing research includes studies of the gut microflora in collaboration with the Center for Individualized Medicine; clinical trials for treatment; and epidemiology and outcomes from infection.
To refer a patient or for an appointment at the C. difficile Clinic, contact the Gastroenterology and Hepatology appointment office at (507) 284-2141.
Source: Mayo Clinic
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.